Economic Burden of Endoscopic Vacuum Therapy Compared to Alternative Therapy Methods in Patients with Anastomotic Leakage After Esophagectomy
-
Published:2021-02-24
Issue:10
Volume:25
Page:2447-2454
-
ISSN:1091-255X
-
Container-title:Journal of Gastrointestinal Surgery
-
language:en
-
Short-container-title:J Gastrointest Surg
Author:
Eichelmann Ann-KathrinORCID, Ismail Sarah, Merten Jennifer, Slepecka Patrycja, Palmes Daniel, Laukötter Mike G., Pascher Andreas, Mardin Wolf Arif
Abstract
Abstract
Background
Endoscopic vacuum therapy (EVT) has become a promising option in the management of anastomotic leakage (AL) after esophagectomy. However, EVT is an effortful approach associated with multiple interventions. In this study, we conduct a comparative cost analysis for methods of management of AL.
Methods
All patients who experienced AL treated by EVT, stent, or reoperation following Ivor Lewis esophagectomy for esophageal cancer were included. Cases that were managed by more than one modality were excluded. For the remaining cases, in-patient treatment cost was collected for material, personnel, (par)enteral nutrition, intensive care, operating room, and imaging.
Results
42 patients were treated as follows: EVT n = 25, stent n = 13, and reoperation n = 4. The mean duration of therapy as well as length of overall hospital stay was significantly shorter in the stent than the EVT group (30 vs. 44d, p = 0.046; 34 vs. 53d, p = 0.02). The total mean cost for stent was €33.685, and the total cost for EVT was €46.136, resulting in a delta increase of 37% for EVT vs. stent cost. 75% (€34.320, EVT), respectively, 80% (€26.900, stent) of total costs were caused by ICU stay. Mean pure costs for endoscopic management were relatively low and comparable between both groups (EVT: €1.900, stent: €1.100, p = 0.28).
Conclusion
Management of AL represents an effortful approach that results in high overall costs. The expenses directly related to EVT and stent therapy were however comparatively low with more than 75% of costs being attributable to the ICU stay. Reduction of ICU care should be a central part of cost reduction strategies.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Surgery
Reference22 articles.
1. Messager, M., Warlaumont, M., Renaud, F., Marin, H., Branche, J., Piessen, G., Mariette, C.: Recent improvements in the management of esophageal anastomotic leak after surgery for cancer. Eur J Surg Oncol 43(2), 258-269 (2017). doi:https://doi.org/10.1016/j.ejso.2016.06.394 2. Markar, S., Gronnier, C., Duhamel, A., Bigourdan, J.M., Badic, B., du Rieu, M.C., Lefevre, J.H., Turner, K., Luc, G., Mariette, C.: Pattern of postoperative mortality after esophageal cancer resection according to center volume: results from a large European multicenter study. Ann Surg Oncol 22(8), 2615-2623 (2015). doi:https://doi.org/10.1245/s10434-014-4310-5 3. Kamarajah, S.K., Lin, A., Tharmaraja, T., Bharwada, Y., Bundred, J.R., Nepogodiev, D., Evans, R.P.T., Singh, P., Griffiths, E.A.: Risk factors and outcomes associated with anastomotic leaks following esophagectomy: a systematic review and meta-analysis. Dis Esophagus 33(3) (2020). doi:10.1093/dote/doz089 4. Laukoetter, M.G., Mennigen, R., Neumann, P.A., Dhayat, S., Horst, G., Palmes, D., Senninger, N., Vowinkel, T.: Successful closure of defects in the upper gastrointestinal tract by endoscopic vacuum therapy (EVT): a prospective cohort study. Surg Endosc 31(6), 2687-2696 (2017). doi:https://doi.org/10.1007/s00464-016-5265-3 5. Dasari, B.V., Neely, D., Kennedy, A., Spence, G., Rice, P., Mackle, E., Epanomeritakis, E.: The role of esophageal stents in the management of esophageal anastomotic leaks and benign esophageal perforations. Annals of surgery 259(5), 852-860 (2014). doi:https://doi.org/10.1097/SLA.0000000000000564
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|